Literature DB >> 26195555

Unexpected Roles for Toll-Like Receptor 4 and TRIF in Intraocular Infection with Gram-Positive Bacteria.

Salai Madhumathi Parkunan1, C Blake Randall2, Phillip S Coburn2, Roger A Astley2, Rachel L Staats3, Michelle C Callegan4.   

Abstract

Inflammation caused by infection with Gram-positive bacteria is typically initiated by interactions with Toll-like receptor 2 (TLR2). Endophthalmitis, an infection and inflammation of the posterior segment of the eye, can lead to vision loss when initiated by a virulent microbial pathogen. Endophthalmitis caused by Bacillus cereus develops as acute inflammation with infiltrating neutrophils, and vision loss is potentially catastrophic. Residual inflammation observed during B. cereus endophthalmitis in TLR2(-/-) mice led us to investigate additional innate pathways that may trigger intraocular inflammation. We first hypothesized that intraocular inflammation during B. cereus endophthalmitis would be controlled by MyD88- and TRIF-mediated signaling, since MyD88 and TRIF are the major adaptor molecules for all bacterial TLRs. In MyD88(-/-) and TRIF(-/-) mice, we observed significantly less intraocular inflammation than in eyes from infected C57BL/6J mice, suggesting an important role for these TLR adaptors in B. cereus endophthalmitis. These results led to a second hypothesis, that TLR4, the only TLR that signals through both MyD88 and TRIF signaling pathways, contributed to inflammation during B. cereus endophthalmitis. Surprisingly, B. cereus-infected TLR4(-/-) eyes also had significantly less intraocular inflammation than infected C57BL/6J eyes, indicating an important role for TLR4 in B. cereus endophthalmitis. Taken together, our results suggest that TLR4, TRIF, and MyD88 are important components of the intraocular inflammatory response observed in experimental B. cereus endophthalmitis, identifying a novel innate immune interaction for B. cereus and for this disease.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26195555      PMCID: PMC4567632          DOI: 10.1128/IAI.00502-15

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  70 in total

1.  Acute inflammation and loss of retinal architecture and function during experimental Bacillus endophthalmitis.

Authors:  Raniyah T Ramadan; Raul Ramirez; Billy D Novosad; Michelle C Callegan
Journal:  Curr Eye Res       Date:  2006-11       Impact factor: 2.424

2.  Failure of intravitreal dexamethasone to diminish inflammation or retinal toxicity in an experimental model of Bacillus cereus endophthalmitis.

Authors:  John S Pollack; Douglas J Beecher; Jose S Pulido; Amy C Lee Wong
Journal:  Curr Eye Res       Date:  2004 Oct-Nov       Impact factor: 2.424

3.  Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product.

Authors:  K Hoshino; O Takeuchi; T Kawai; H Sanjo; T Ogawa; Y Takeda; K Takeda; S Akira
Journal:  J Immunol       Date:  1999-04-01       Impact factor: 5.422

4.  Meta-analysis of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents: causative organisms and possible prevention strategies.

Authors:  Colin A McCannel
Journal:  Retina       Date:  2011-04       Impact factor: 4.256

5.  TLR4 and TLR5 on corneal macrophages regulate Pseudomonas aeruginosa keratitis by signaling through MyD88-dependent and -independent pathways.

Authors:  Yan Sun; Mausita Karmakar; Sanhita Roy; Raniyah T Ramadan; Susan R Williams; Scott Howell; Carey L Shive; Yiping Han; Charles M Stopford; Arne Rietsch; Eric Pearlman
Journal:  J Immunol       Date:  2010-09-08       Impact factor: 5.422

6.  ExoS and ExoT ADP ribosyltransferase activities mediate Pseudomonas aeruginosa keratitis by promoting neutrophil apoptosis and bacterial survival.

Authors:  Yan Sun; Mausita Karmakar; Patricia R Taylor; Arne Rietsch; Eric Pearlman
Journal:  J Immunol       Date:  2012-01-16       Impact factor: 5.422

7.  Effects of intravitreal moxifloxacin and dexamethasone in experimental Staphylococcus aureus endophthalmitis.

Authors:  Sitki Samet Ermis; Zafer Cetinkaya; Halil Kiyici; Umit Ubeyt Inan; Faruk Ozturk
Journal:  Curr Eye Res       Date:  2007-04       Impact factor: 2.424

8.  Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection.

Authors:  Richard Malley; Philipp Henneke; Sarah C Morse; Michael J Cieslewicz; Marc Lipsitch; Claudette M Thompson; Evelyn Kurt-Jones; James C Paton; Michael R Wessels; Douglas T Golenbock
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-04       Impact factor: 11.205

9.  Nuclear factor translocation and acute anterior uveitis.

Authors:  Jing Wang; Hong Lu; Xiaofeng Hu; Wei Chen; Zhuozai Xu; Shang Li; Yingzhi Xu
Journal:  Mol Vis       Date:  2011-01-18       Impact factor: 2.367

10.  Anthrolysin O and other gram-positive cytolysins are toll-like receptor 4 agonists.

Authors:  Jin Mo Park; Vincent H Ng; Shin Maeda; Richard F Rest; Michael Karin
Journal:  J Exp Med       Date:  2004-12-20       Impact factor: 14.307

View more
  20 in total

Review 1.  Targets of immunomodulation in bacterial endophthalmitis.

Authors:  Frederick C Miller; Phillip S Coburn; Mursalin Md Huzzatul; Austin L LaGrow; Erin Livingston; Michelle C Callegan
Journal:  Prog Retin Eye Res       Date:  2019-05-28       Impact factor: 21.198

2.  TanshinoneIIA Alleviates Inflammatory Response and Directs Macrophage Polarization in Lipopolysaccharide-Stimulated RAW264.7 Cells.

Authors:  Shan Gao; Yili Wang; Dan Li; Yuying Guo; Meifeng Zhu; Shixin Xu; Jingyuan Mao; Guanwei Fan
Journal:  Inflammation       Date:  2019-02       Impact factor: 4.092

3.  Glycolytic inhibitor 2-deoxyglucose suppresses inflammatory response in innate immune cells and experimental staphylococcal endophthalmitis.

Authors:  Rebecca Francis; Pawan Kumar Singh; Sukhvinder Singh; Shailendra Giri; Ashok Kumar
Journal:  Exp Eye Res       Date:  2020-05-23       Impact factor: 3.467

Review 4.  Modeling intraocular bacterial infections.

Authors:  Roger A Astley; Phillip S Coburn; Salai Madhumathi Parkunan; Michelle C Callegan
Journal:  Prog Retin Eye Res       Date:  2016-05-03       Impact factor: 21.198

5.  The role of pili in Bacillus cereus intraocular infection.

Authors:  Michelle C Callegan; Salai Madhumathi Parkunan; C Blake Randall; Phillip S Coburn; Frederick C Miller; Austin L LaGrow; Roger A Astley; Craig Land; So-Young Oh; Olaf Schneewind
Journal:  Exp Eye Res       Date:  2017-03-20       Impact factor: 3.467

6.  5-Aminoimidazole-4-carboxamide ribonucleoside-mediated adenosine monophosphate-activated protein kinase activation induces protective innate responses in bacterial endophthalmitis.

Authors:  Ajay Kumar; Shailendra Giri; Ashok Kumar
Journal:  Cell Microbiol       Date:  2016-07-26       Impact factor: 3.715

7.  CXCL1, but not IL-6, significantly impacts intraocular inflammation during infection.

Authors:  Salai Madhumathi Parkunan; C Blake Randall; Roger A Astley; Glaucia C Furtado; Sergio A Lira; Michelle C Callegan
Journal:  J Leukoc Biol       Date:  2016-06-10       Impact factor: 4.962

8.  Toll-like receptor 2 (TLR2) engages endoplasmic reticulum stress sensor IRE1α to regulate retinal innate responses in Staphylococcus aureus endophthalmitis.

Authors:  Ajay Kumar; Pawan Kumar Singh; Kezhong Zhang; Ashok Kumar
Journal:  FASEB J       Date:  2020-08-19       Impact factor: 5.191

9.  Intravitreal Injection and Quantitation of Infection Parameters in a Mouse Model of Bacterial Endophthalmitis.

Authors:  Md Huzzatul Mursalin; Erin Livingston; Phillip S Coburn; Frederick C Miller; Roger Astley; Michelle C Callegan
Journal:  J Vis Exp       Date:  2021-02-06       Impact factor: 1.355

10.  Immune Inhibitor A Metalloproteases Contribute to Virulence in Bacillus Endophthalmitis.

Authors:  Erin T Livingston; Md Huzzatul Mursalin; Phillip S Coburn; Roger Astley; Frederick C Miller; Omar Amayem; Didier Lereclus; Michelle C Callegan
Journal:  Infect Immun       Date:  2021-06-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.